Eduardo Carlos
Salido Ruiz
Catedrático de Universidad
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (7)
2021
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2019
-
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses
Human Molecular Genetics, Vol. 28, Núm. 1, pp. 1-15
2018
-
Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679] (S0168827817320469) (10.1016/j.jhep.2017.05.010))
Journal of Hepatology
-
Renal disease in obesity, metabolic syndrome and diabesity
Diabetic Nephropathy: Pathophysiology and Clinical Aspects (Springer International Publishing), pp. 65-80
2017
-
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679
2009
-
TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis
Nephrology Dialysis Transplantation, Vol. 24, Núm. 10, pp. 3089-3096
2008
-
Expression of DNA damage checkpoint protein Hus1 in epithelial ovarian tumors correlates with prognostic markers
International Journal of Gynecological Pathology, Vol. 27, Núm. 1, pp. 24-32